Work

Tricuspid Regurgitation Risk Scores in Patients Undergoing Tricuspid Valve Transcatheter Edge-To-Edge Repair

Year: 2025

Type: article

Abstract: Tricuspid regurgitation (TR) is associated with increased morbidity, mortality and the risk of frequent heart failure hospitalizations. Tricuspid transcatheter edge-to-edge repair (T-TEER) evolved as a powerful technique for the effective treatment of TR without the need for open-heart surgery. Recent data of two randomized controlled trials demonstrated significant improvement of quality of life by T-TEER in addition to optimal medical therapy.1, 2 Beyond that, safety and effectiveness of T-TEER have been confirmed in several real-world registries.3-6 However, improvement of heart failure hospitalizations or mortality following T-TEER has not been observed yet. Therefore, careful patient selection prior to T-TEER is key to further optimize outcomes and potentially reduce mortality of heart failure patients with severe TR. Several TR risk scores are available which were mostly designed and validated to predict early survival prognosis in surgically or conventionally treated TR patients. The aim of this study was to evaluate the performance of six currently available risk scores in a large real-world T-TEER cohort for the prediction of 1-year survival.

Source: European Journal of Heart Failure

DOI: 10.1002/ejhf.3599